Anti-PD-L1 [BT613]

Catalogue Number: AB03784-10.0-ABA

Manufacturer:Vector Laboratories, Inc (ABA)
Type:Recombinant Monoclonal
Alias:CD274; B7-H1; B7 homolog 1; PDCD1 ligand 1; Programmed death ligand 1; hPD-L1; Programmed cell death 1 ligand 1
Shipping Condition:Blue Ice
Unit(s): 0.1 mg
Host name: Human
Clone: BT613
Isotype: IgG1
Immunogen: The original antibody was generated by immunizing transgenic mice with PD-L1, followed by antibody library construction and phage display-based selection against PD-L1.
Application: Blk, Inh, InVitroA, InVivoA, SPR

Additional Text

Gene Name

CD274

Gene ID

29126

Uniprot ID

Q9NZQ7

Purification

Purified

Antibody Clonality

Recombinant Monoclonal

Storage Note

Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.

Application Notes

The binding affinity of the antibody to PD-L1 was measured by surface plasmon resonance. The binding affinity of the antibody was measured on the cell lines with high expression of PD-L1 by FACS. The specificity of the original format of the antibody was confirmed by ELISA analysis. The antibody had good activity in blocking the binding of PD-L1 to PD-1 and PD-L1 to B7-1 is shown by ELISA analysis. The antibody could block the binding of PD-1 and PD-L1 at the cellular level in in vitro experiments. The antibody was used for in vivo experiments on colon cancer tumor model. B-hPD-1 mice with human PD-1 and MC38-hPD-L1 colon cancer cells with human PD-L1 were treated with the antibody. Results showed inhibition of tumor volume growth in mice treated with the antibody.